Kyung Ai Chae, MD
Dermatology · Manitowoc, WINPI 1932101060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $645 and has fallen 69.4% since, to $197 in 2025.
Across 104 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$325
- E.r. Squibb & Sons, L.L.C.$233
- Bristol Myers Squibb$193
- Regeneron Healthcare Solutions, Inc.$184
- AbbVie$166
- Johnson & Johnson$140
- plus $871 from 17 others
What the payments were for
- Food & beverage$1,95793%
- Education$1557%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 23 | $325 |
| E.r. Squibb & Sons, L.L.C. | 12 | $233 |
| Bristol Myers Squibb | 8 | $193 |
| Regeneron Healthcare Solutions, Inc. | 7 | $184 |
| AbbVie | 8 | $166 |
| Johnson & Johnson | 4 | $140 |
| Lilly USA, LLC | 7 | $140 |
| Amgen | 4 | $102 |
| UCB, Inc. | 4 | $89 |
| Sanofi | 4 | $87 |
| Dermira, Inc. | 4 | $74 |
| Novartis | 4 | $73 |
| Incyte Corporation | 3 | $62 |
| LEO Pharma Inc. | 2 | $53 |
| Revance Therapeutics, Inc. | 1 | $39 |
| Pfizer | 2 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Biofrontera Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Prugen, Inc. Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$125
How this compares
$2,112 in reported general payments places this provider in the 75th percentile of 260 dermatology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 11 | $793 |
| Ketoconazole | 30 | $505 |
| Clobetasol Propionate | 12 | $413 |
| Nystatin | 13 | $164 |
| Doxycycline Monohydrate | 11 | $122 |
| Triamcinolone Acetonide | 18 | $99 |
| Mupirocin | 16 | $88 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Manitowoc
- Betsy WernliManitowoc$177K
- Azam QureshiManitowoc$11K
- David NelsenJanesville$1.1M
- Gabriela MaloneyOconomowoc$725K
- Kenneth GordonWauwatosa$577K
- Ashley DietrichMilwaukee$466K
- Martin OkunFort Atkinson$232K
- Daniel OpelSheboygan$118K
- Stephen LewellisPlover$73K
- Patrick SafoStevens Point$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.